Showing 1 - 20 results of 42 for search 'José Luis Gorriz', query time: 0.06s
Refine Results
-
1
-
2
-
3
-
4
Esteatosis hepática metabólica y nefropatía diabética: una llamada a la acción by Salvador Benlloch, Francesc Moncho, Jose Luis Górriz
Published 2024-03-01
Article -
5
-
6
Effect of SGLT2 inhibitors on anemia and their possible clinical implications by Aleix Cases, Secundino Cigarrán, José Luis Górriz, Julio Nuñez
Published 2024-03-01
Article -
7
-
8
-
9
Impact of an article in the social age: Is tweeting the same as citing? by Marco Montomoli, Omar Taco Sanchez, Luis D’Marco, José Luis Gorriz Teruel
Published 2022-03-01
Article -
10
-
11
-
12
Cardiorenal benefits of finerenone: protecting kidney and heart by José R. González-Juanatey, Jose Luis Górriz, Alberto Ortiz, Alfonso Valle, Maria Jose Soler, Lorenzo Facila
Published 2023-12-01
Article -
13
Concentración de hemoglobina reticulocitaria y ferroterapia en la enfermedad renal crónica: respuesta del grupo de Anemia de la Sociedad Española de Nefrología by Aleix Cases, Patricia de Sequera, Borja Quiroga, Maria Jesús Puchades, Leyre Martin-Rodriguez, José Luis Gorriz, José Portolés
Published 2023-09-01
Article -
14
Reticulocyte hemoglobin content and iron therapy in chronic kidney disease: Reply of the Anemia group of the Spanish Society of Nephrology by Aleix Cases, Patricia de Sequera, Borja Quiroga, Maria Jesús Puchades, Leyre Martin-Rodriguez, José Luis Gorriz, José Portolés
Published 2023-09-01
Article -
15
-
16
-
17
Effect of the use of dapagliflozin in diuresis, natriuriesis, and in ultrafiltration and peritoneal elimination of sodium in patients with refractory heart failure: DAPA-DP study by Marco Montomoli, Camila Solano Rivera, Miguel Gonzalez Rico, Rafael De la Espriella Juan, Gonzalo Nuñez Marín, Maria Jesús Puchades Montesa, Jose Luis Gorriz Teruel
Published 2024-12-01
Article -
18
SGLT2i and GLP-1RA in Cardiometabolic and Renal Diseases: From Glycemic Control to Adipose Tissue Inflammation and Senescence by Luis D'Marco, Valery Morillo, José Luis Gorriz, María K. Suarez, Manuel Nava, Ángel Ortega, Heliana Parra, Nelson Villasmil, Joselyn Rojas-Quintero, Valmore Bermúdez
Published 2021-01-01
Article -
19
-
20
Proteinuria-Lowering Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Chronic Kidney Disease Patients: A Real-World Multicentric Study by Patricia Muñoz Ramos, Yohana Gil Giraldo, Vicente Álvarez-Chiva, David Arroyo, Cristina Sango Merino, Francesc Moncho Francés, Javier Ocaña, Javier Reque, Emilio Sánchez-Álvarez, José Luis Górriz, Borja Quiroga
Published 2021-11-01
Article